Bio Medica Laboratories Financials

NSE: BMLL

₹148.20

up-down-arrow ₹-1.80 (-1.20%)

As on 16-Nov-2026IST

Market cap

info icon

₹186 Cr

Revenue (TTM)

info icon

₹43 Cr

P/E Ratio

info icon

15.8

P/B Ratio

info icon

6.2

Div. Yield

info icon

0 %

Income Statement (₹ Cr)

Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Operating Revenue
43.09
38.32
--
--
--
--
Total Income
43.11
38.33
--
--
--
--
Total Expenditure
23.11
22.82
--
--
--
--
EBITDA
19.98
15.50
--
--
--
--
Depreciation
1.16
1.01
--
--
--
--
EBIT
18.81
14.49
--
--
--
--
Interest
2.58
1.35
--
--
--
--
Other Income
0.02
0.01
--
--
--
--
Exceptional Items
--
--
--
--
--
--
Profit before Tax
16.25
13.14
--
--
--
--
Provision for Tax
4.37
3.44
--
--
--
--
Profit after Tax
11.89
9.70
--
--
--
--
Minority Interest
-0.11
--
--
--
--
--
Share of Associate
--
--
--
--
--
--
Consolidated Profit
11.78
9.70
--
--
--
--

Liabilities (₹ Cr)

Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Shareholder's Funds
26.51
14.73
--
--
--
--
Minority Interest
-6.17
--
--
--
--
--
Non-Current Liabilities
33.45
10.51
--
--
--
--
Current Liabilities
19.18
13.26
--
--
--
--
Total Liabilities
73.31
38.70
--
--
--
--

Assets (₹ Cr)

Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Non-Current Assets
18.31
7.85
--
--
--
--
Current Assets
54.67
30.65
--
--
--
--
Total Assets
73.31
38.70
--
--
--
--
Total Debt*
39.99
15.01
--
--
--
--
Net Current Assets
35.48
17.39
--
--
--
--
Contingent Liabilities
--
--
--
--
--
--

Cashflow (₹ Cr)

Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Cash From Operating Activities
-6.03
-4.57
--
--
--
--
Cash Flow from Investing Activities
-2.31
0.05
--
--
--
--
Cash from Financing Activities
8.43
4.52
--
--
--
--
Net Cash Inflow / Outflow
0.09
0.00
--
--
--
--

Financials Ratios

Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Adjusted EPS (₹) info
12.83
10.57
--
--
--
--
Cash EPS (₹) info
14.22
11.67
--
--
--
--
Adjusted Book Value (₹) info
28.88
16.05
--
--
--
--
Dividend per Share (₹) info
--
--
--
--
--
--
Cash Flow per Share (₹) info
-6.57
-4.98
--
--
--
--
Free Cash Flow per Share (₹) info
-12.52
-4.88
--
--
--
--

Profitability Ratios

Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
ROCE (%) info
39.14
48.73
--
--
--
--
ROE (%) info
57.64
65.87
--
--
--
--
ROA (%) info
21.33
25.20
--
--
--
--
EBIT Margin (%) info
43.66
37.82
--
--
--
--
Net Margin (%) info
27.57
25.32
--
--
--
--
Cash Profit Margin (%) info
30.29
27.95
--
--
--
--

Growth Ratios

Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Revenue Growth (%) info
12.45
--
--
--
--
--
EBIT Growth (%) info
29.82
--
--
--
--
--
Net Profit Growth (%) info
22.50
--
--
--
--
--
EPS Growth (%) info
21.40
--
--
--
--
--
Book Value Growth (%) info
79.96
--
--
--
--
--

Valuation Ratios

Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Price / Earnings info
--
--
--
--
--
--
Price / Book Value info
--
--
--
--
--
--
Dividend Yield (%) info
--
--
--
--
--
--
EV/EBITDA info
2.45
1.56
--
--
--
--
Close Price (₹) info
--
--
--
--
--
--
High Price (₹) info
--
--
--
--
--
--
Low Price (₹) info
--
--
--
--
--
--
Market Cap (₹ Cr) info
--
--
--
--
--
--

Solvency Ratios

Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Debt to Equity info
1.51
1.02
--
--
--
--
Short term debt to equity ratio info
0.22
0.21
--
--
--
--
Current Ratio info
2.85
2.31
--
--
--
--
Quick Ratio info
0.95
0.94
--
--
--
--
Interest Coverage info
7.29
10.71
--
--
--
--

Operating Efficiency Ratios

Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18 Mar-17 Mar-16
Debtors to sales (%) info
25.19
10.70
--
--
--
--
Asset Turnover info
0.77
1.00
--
--
--
--
Receivable days info
63.33
39.05
--
--
--
--
Inventory Days info
230.85
172.77
--
--
--
--
Payable days info
181.09
159.82
--
--
--
--
Cash Conversion Cycle info
113.10
52.00
--
--
--
--
loading...
loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month